Gilead Sciences Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Gilead Sciences Inc
TickerGILD
CIK #0000882095
CUSIP375558103
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address333 Lakeside Dr, Foster City, CA 94404
Source [EDGAR]
CIK Filing 2011 - 2025
[0000882095] 10-K
[0000882095] 10-Q
[0000882095] 13F-HR
[0000882095] 3
[0000882095] 4
[0000882095] 5
[0000882095] 8-K
[0000882095] SC 13D
[0000882095] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Gilead Sciences Inc LEAP Therapeutics Inc [2024-04-19] 819413.9
Gilead Sciences Inc Xilio Therapeutics Inc [2024-04-05] 819419.9
Gilead Sciences Inc Kyverna Therapeutics Inc [2024-02-20] 8194.0
Gilead Sciences Inc Assembly Biosciences Inc [2023-10-25] 19.9
Gilead Sciences Inc Ikena Oncology Inc [2023-10-19] 6.7
Capital World Investors Gilead Sciences Inc [2023-02-13] 5.5
Gilead Sciences Inc Arcellx Inc [2023-02-06] 7.3
Gilead Sciences Inc Allovir Inc [2022-08-08] 14.8
BlackRock Inc Gilead Sciences Inc [2022-07-08] 10.1
Gilead Sciences Inc Agenus Inc [2022-02-10] 4.3
Gilead Sciences Inc Tango Therapeutics Inc [2021-09-10] 5.5
Gilead Sciences Inc Jounce Therapeutics Inc [2020-10-26] 13.9
Gilead Sciences Inc Arcus Biosciences Inc [2020-07-17] 35.0
Gilead Sciences Inc Sierra Oncology Inc [2020-02-10] 9.99
Gilead Sciences Inc Galapagos NV [2019-07-23] 12.3
Gilead Sciences Inc Hookipa Pharma Inc [2019-05-03] 7.7
Capital Research Global Investors Gilead Sciences Inc [2019-02-14] 5.6
Gilead Sciences Inc Allogene Therapeutics Inc [2019-02-13] 6.2
Gilead Sciences Inc Agenus Inc [2019-01-29] 0.3
Gilead Sciences Inc Galapagos NV [2016-01-27] 14.8
Vanguard Group Inc Gilead Sciences Inc [2015-02-10] 5.4
Price T Rowe Associates Inc /MD/ Gilead Sciences Inc [2014-02-11] 5.0
FMR LLC Gilead Sciences Inc [2013-02-14] 0.0
Growth Fund of America Inc Gilead Sciences Inc [2013-02-13] 6.8
Capital World Investors Gilead Sciences Inc [2013-02-13] 7.0
Capital Research Global Investors Gilead Sciences Inc [2012-02-14] 5.5
Form 3/4/5 Filer 2011 - 2025
Dickinson Andrew D
Gilead Sciences Inc
Mercier Johanna
O'Day Daniel Patrick
Telman Deborah H
Bluestone Jeffrey
Wilfong Diane E.
Xilio Therapeutics, Inc.
Barton Jacqueline K
Manwani Harish
Horning Sandra
Welters Anthony
Rodriguez Javier
Love Ted W
Kramer Kelly A.
Patterson Sandra
Berger Dietmar
Arcus Biosciences, Inc.
Assembly Biosciences Inc
Parsey Merdad
LEAP Therapeutics Inc
Lofton Kevin E
Kyverna Therapeutics, Inc.
Arcellx, Inc.
HOOKIPA Pharma Inc.
Kalaris Therapeutics, Inc.
Pletcher Brett A
WOLD Olsen PER
Whitley Richard James
Jounce Therapeutics, Inc.
Wilson Gayle E
Cogan John Francis
Hamill Laura
Washington Robin L
Alton Gregg H
McHutchison John G
Martin John C
Milligan John F
Moore Nicholas G
Bischofberger Norbert W
Young Kevin
Meyers James R
Madigan John W
Carter Paul Rutherford
Hills Carla A
Davignon Etienne
Denny James M
Metza Kristen
Moore Gordon Earle
Form 13F Holdings
Firm Period DFND Voting Shares
BlackRock, Inc. [2025-06-30] SOLE 103,260,674 114,878,166
Vanguard Group Inc [2025-06-30] SOLE 0 113,095,884
FMR LLC [2025-06-30] DFND 51,918,315 59,955,377
State Street Corp [2025-06-30] DFND 35,410,023 59,188,160
Capital World Investors [2025-06-30] DFND 46,012,805 46,303,299
Wellington Management Group LLP [2025-06-30] DFND 0 37,530,510
Capital Research Global Investors [2025-06-30] DFND 31,091,248 31,097,679
Dodge & Cox [2025-06-30] SOLE 29,619,922 30,818,322
Geode Capital Management LLC [2025-06-30] DFND 29,160,690 29,207,662
Morgan Stanley [2025-06-30] DFND 12,775,998 22,835,109
Norges Bank [2025-06-30] SOLE 19,394,502 19,394,502
Bank of America Corp /DE/ [2025-06-30] DFND 1,333,583 19,191,304
JPMorgan Chase & Co [2025-06-30] DFND 15,845,423 19,047,509
Northern Trust Corp [2025-06-30] DFND 13,817,987 13,953,345
Invesco Ltd. [2025-06-30] DFND 0 13,521,228
Bank of New York Mellon Corp [2025-06-30] DFND 11,369,426 13,165,909
Amundi [2025-06-30] DFND 10,467,411 10,467,411
Legal & General Group Plc [2025-06-30] DFND 9,016,797 9,796,145
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME [2025-06-30] SOLE 5,556,516 8,782,920
Citadel Advisors LLC [2025-06-30] DFND 8,640,245 8,640,245
Charles Schwab Investment Management Inc [2025-06-30] SOLE 7,999,762 8,000,074
Dimensional Fund Advisors LP [2025-06-30] SOLE 7,509,120 7,869,855
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME [2025-06-30] DFND 3,903,666 7,461,852
Ameriprise Financial Inc [2025-06-30] DFND 0 6,748,403
Wells Fargo & Company/MN [2025-06-30] DFND 519,540 6,470,688
Royal Bank of Canada [2025-06-30] DFND 6,170,499 6,417,919
Allianz Asset Management GmbH [2025-06-30] DFND 3,367,128 6,361,717
Vanguard Group Inc [2025-06-30] DFND 1,872 6,268,342
Goldman Sachs Group Inc [2025-06-30] DFND 6,032,622 6,260,360
AllianceBernstein LP [2025-06-30] DFND 5,439,967 6,144,790
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com